| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8836767 | Surgery | 2018 | 15 Pages |
Abstract
Postoperative CA19-9 levels and tumor grade are two well-known PC biologic markers that could be incorporated into a standard AJCC staging system to refine risk stratification and predict OS benefit from adjuvant chemotherapy in resected PC.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Liang Liu, Hua-Xiang Xu, Min He, Wei Wang, Wen-Quan Wang, Chun-Tao Wu, Rong-Qiang Wei, Yun Liang, He-Li Gao, Chen Liu, Jin Xu, Jiang Long, Quan-Xing Ni, Cheng-Hao Shao, Jian Wang, Xian-Jun Yu,